Diego Pichardo, MD.

I feel truly grateful and blessed for the opportunity to start my first clinical position as a #Neurosurgery Preresidency Fellow in New York. Forever thankful to my mentors for their support and excited for the work ahead! 🙏🏼✝️

Wrapped up SNIS 22nd in Nashville — what a fantastic city! Great time catching up with friends and colleagues @SNISinfo #SNIS2025 #Nashville

Just Published in Operative Neurosurgery: @NeurosurgeryCNS In this multicenter collab of 157 patients, we report the experience of performing Middle Meningeal Artery Embolization (MMAE) with concomitant surgical evacuation as a single session for the treatment of symptomatic…

🧠 New publication in Epilepsia! During the evaluation of epileptic networks in drug-resistant epilepsy, SEEG-guided radiofrequency thermocoagulation can improve seizure burden and even result in seizure freedom in some patients! Work led by @PavelPichardoMD , under the guidance…

📢 New publication! Our latest article in Epilepsia Open evaluates the long-term outcomes of corpus callosotomy in adults with drug-resistant epilepsy. 🔹 73.8% of patients had a ≥50% seizure reduction at long-term follow-up (>3y). 🔹 Despite most studies presenting the…

Check out our long term experience with corpus callosotomy in adults at @INNNMVS. Great job @DiegoPichardoMD! Open access link: doi.org/10.1002/epi4.7…

Accelerated titration programming in VNS implantation for refractory status epilepticus is effective. Our experience at @INNNMVS and a systematic review! @DiegoPichardoMD To view: doi.org/10.1002/epd2.7…

🧠 New publication! Super Refractory Status Epilepticus carries a mortality of 25-40%, yet treatment options remain limited. In our systematic review & case series, Vagus Nerve Stimulation was associated with an 87.9% resolution rate. VNS can be considered after 2 weeks of…

Amazing news for all IMGs aspiring to do their residency or research fellowships in the USA!

Wonderful news to all IMG! j1 visa are being opened again!!

#TBT to a study by Kondziolka et al. (NEJM '98): Stereotactic radiosurgery achieved 98% long-term tumor control for acoustic neuromas, with excellent facial and trigeminal nerve preservation. A pivotal shift toward less invasive neurosurgical care. nejm.org/doi/full/10.10…

Proud to share our latest study! While reoperation at GBM recurrence remains debated, achieving CRET <1cm³ correlates with 46% improved survival vs. partial resection. Standardized volumetric classifications are key to define surgery’s role. Link ⬇️@EsquenaziMD @JNeurooncol

Extremely packed session at the Tumor Soirée by the @NSTumorSection AANS/CNS, bringing together outstanding leaders in neuro-oncology for an engaging discussion. #AANS2025 @AANSNeuro

An honor meeting @NitinAgarwalMD! Thanks for making neurosurgery more approachable for all students. #AANS2025

Keep the faith. As long as you choose to be positive, you’ll rise above all adversity and challenges. There’s always hope!

Fantastic @OU_Neurosurgery representation at #AANS2025! Proud to see so many of our students, residents, & junior faculty getting involved w #E2M in particular 🤓

Honored to be able to work with neurosurgeons who are passionate and constantly pushing the boundaries of their field. Amazing way to kick off #AANS2025! @EsquenaziMD

New publication out now in the Journal of Neuropathology & Experimental Neurology! We show that MTAP immunohistochemistry can serve as a cost-effective marker for CDKN2A deletion in brain tumors (92% Sen, 97% Spe). Great for Meningiomas and Gliomas! A major step toward more…

Excited to share that I’ll be attending #AANS2025 in Boston this year, where I’ll be presenting 7 research abstracts 🧠📊 If you’ll be there too—comment or DM me! I’d love to connect with peers and faculty. Always open to new collaborations and research opportunities. Let’s meet!…